Multitargeted anti-infective drugs: resilience to resistance in the antimicrobial resistance era

Research output: Contribution to journalReview articlepeer-review

30 Downloads (Pure)

Abstract

The standard drug discovery paradigm of single molecule - single biological target - single biological effect is perhaps particularly unsuitable for anti-infective drug discovery. This is due to the rapid evolution of resistance likely to be observed with single target drugs. Multi-targeted anti-infective drugs (MTAIDs) are likely to be superior due to their lower susceptibility to target-related resistance mechanisms. Strathclyde Minor Groove Binders (S-MGBs) are a class of compounds which have been developed by adopting the MTAID paradigm, and their effectiveness against a wide range of pathogenic organisms is discussed. The renaming of this class to Strathclyde Nucleic Acid Binders (SNABs) is also presented due to their likely targets including both DNA and RNA.
Original languageEnglish
Number of pages14
JournalFuture Drug Discovery
Volume4
Issue number1
Early online date5 May 2022
DOIs
Publication statusPublished - 5 May 2022

Keywords

  • anti-infectives
  • multi-targeting anti-infective drugs
  • antimicrobial resistance
  • Strathclyde Minor Groove Binders (S-MGBs)
  • Strathclyde Nucleic Acid Binders (SNABs)
  • nucleic acids
  • RNA

Fingerprint

Dive into the research topics of 'Multitargeted anti-infective drugs: resilience to resistance in the antimicrobial resistance era'. Together they form a unique fingerprint.

Cite this